Anodyne Therapy, LLC Develops Device For Treatment of Foot and Leg Pain And Pledges Donation In Honor Of World Dia...(nt a large portion of our patient base f...),Health

Date:11/6/2009

nt a large portion of our patient base for Anodyne home units as well as the patients seen in the more than 6,000 healthcare facilities that administer professional Anodyne Therapy treatments. We would like to offer more to the diabetic community than pain relief. Therefore, we are joining thousands of other supporters of Diabetes Awareness Month and of World Diabetes Day to enhance diabetic awareness and education to reduce diabetic foot complications across the globe.”

The International Diabetes Federation (IDF), in its statement issued in October 2009, reported that the number of people with diabetes continues to grow rapidly throughout the world with more than 440 million people estimated to be affected within the next 20 years. During their most recent meeting in Montreal, the IDF stressed prevention of complications associated with diabetes prior to their manifestation.

Recipients of Anodyne Therapy’s donation will be two non-profit organizations, a start up NPO, “Wound Care Haiti” and the IDF’s “Life for a Child Program”. The mission of “Wound Care Haiti” is to establish a limb amputation prevention program in Haiti, by providing preventative foot care, supplies and education to the country’s diabetic population. Anodyne Therapy has additionally pledged the donation of 2 Anodyne Therapy Professional Systems to aid Wound Care Haiti in their efforts. The IDF’s “Life for a Child Program” supports children with diabetes globally by providing appropriate medical supplies and education.

Note to Editors: Anodyne Therapy, LLC was formed in 2001 and is a privately held company based in Tampa, Florida. Anodyne Therapy is committed to improving the quality of life of patients through the use of its drug-free and topically applied medical devices. 13 Published Peer Reviewed Studies document the efficacy of Anodyne Therapy Professional Systems, and over 6,000 healthc
'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

1 GOOD

Page: 1 2 3
Related medicine news :

1. RevenueMed and Anodyne Health Partner to Raise the Standard of Payment Posting Services
2. Xanodynes New Drug Application for the Treatment of Heavy Menstrual Bleeding (Menorrhagia) Accepted for Filing with a Priority Review Classification
3. Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
4. Xanodyne Announces Appointment of Mr. Vaughn M. Kailian of MPM Capital to the Board of Directors
5. Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
6. U.S. Food and Drug Administration and Xanodyne Agree on a Plan to Keep Propoxyphene-Containing Products Available as Treatment Options for the Management of Mild to Moderate Pain
7. To evade chemotherapy, some cancer cells mimic stem cells
8. Smoking Cessation Rates Double With Intensive Counseling and Free Nicotine Replacement Therapy, Studies of 20,000 Smokers Show
9. American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Womens Shelters
10. Skin flaps deliver cancer-fighting therapy, ASPS study reveals
11. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes